NeuroOne Medical Technologies Corporation (NMTC) Balance Sheet
NMTC balance sheet, FY2025
September 30, 2025 · U.S. dollars$10.8M assets = $3.7M liabilities + $7.1M equity
Both columns are drawn to the same scale: what NMTC owns equals what it owes plus shareholders’ equity. Hover a block for its value.
NMTC financial health
Descriptive bands, not a rating. Fiscal FY2025.
NMTC balance sheet trends, FY2016–FY2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $1,838FY2016 | $10.8MFY2025 | +162.3%/yr | |
| Total liabilities | $83,330FY2016 | $3.7MFY2025 | +52.5%/yr | |
| Shareholders’ equity | −$81,492FY2016 | $7.1MFY2025 | — | |
| Cash & short-term investments | −$1,838FY2016 | $6.6MFY2025 | — | |
| Total debt | $13,619FY2016 | $266,806FY2025 | +39.2%/yr | |
| Net cash (debt) | −$15,457FY2016 | $6.3MFY2025 | +$6.3M | |
| Working capital | −$81,492FY2016 | $7.9MFY2025 | +$8.0M | |
| Book value per share | $3.60FY2022 | $1.06FY2025 | −33.6%/yr | |
| Current ratio | 0.02FY2016 | 4.44FY2025 | +4.42 | |
| Debt / equity | 0.64FY2020 | 0.04FY2025 | −0.60 | |
| Shares outstanding | 2.7MFY2022 | 6.7MFY2025 | +35.9%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
NMTC assets
NMTC liabilities and equity
NMTC debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
NMTC balance sheet
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $6.6M | $1.5M | $5.3M | $11.1M | $6.9M | $4.0M | $260,749 | $13,260 | $522,217 | −$1,838 |
| Cash & equivalents | $6.6M | $1.5M | $5.3M | $8.2M | $6.9M | $4.0M | $260,749 | $13,260 | $522,217 | −$1,838 |
| Short-term investments | — | — | $0 | $3.0M | $0 | — | — | $0 | $0 | $0 |
| Receivables | $1.3M | $176,636 | $0 | $33,237 | $48,336 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $2.2M | $2.6M | $1.7M | $704,538 | $98,287 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $164,292 | $359,094 | $263,746 | $296,649 | $244,043 | $118,611 | $41,002 | $5,378 | $53,823 | $3,676 |
| Total current assets | $10.2M | $4.6M | $7.3M | $12.2M | $7.3M | $4.2M | $301,751 | $18,638 | $576,040 | $1,838 |
| Property, plant & equipment (net) | $514,417 | $671,753 | $694,812 | $534,954 | $512,277 | $448,242 | $52,026 | $0 | $0 | $0 |
| Goodwill & intangible assets | $44,946 | $67,262 | $89,577 | $111,892 | $134,207 | $156,523 | $178,838 | $200,081 | $180,890 | $100,293 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total assets | $10.8M | $5.4M | $8.1M | $12.8M | $7.9M | $4.8M | $532,615 | $218,719 | $756,930 | $1,838 |
| Liabilities | ||||||||||
| Accounts payable | $1.0M | $1.0M | $685,104 | $927,662 | $528,829 | $762,538 | $1.2M | $221,235 | $22,362 | $10,857 |
| Short-term debt | $123,658 | $65,768 | $129,116 | $83,339 | $112,778 | $1.1M | — | $1.7M | $275,197 | $13,619 |
| Deferred revenue | — | — | −$129,116 | $1.5M | $8,622 | $73,434 | — | $1.6M | $73,758 | $52,652 |
| Total current liabilities | $2.3M | $2.2M | $1.8M | $3.1M | $1.2M | $2.4M | $1.8M | $3.8M | $677,190 | $83,330 |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $266,806 | $260,160 | $55,284 | $202,895 | $315,673 | $312,176 | — | $0 | $0 | $0 |
| Other long-term liabilities | $1.4M | $2.3M | $55,284 | $119,556 | $202,895 | $337,661 | $1.2M | $817,155 | $345,960 | $0 |
| Total liabilities | $3.7M | $4.5M | $1.8M | $3.2M | $1.4M | $2.7M | $1.8M | $4.6M | $1.0M | $83,330 |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $50,006 | $30,816 | $23,929 | $16,217 | $12,010 | $22,181 | $13,494 | $9,657 | $31 | $5,073 |
| Retained earnings (deficit) | −$78.6M | −$75.0M | −$62.7M | −$50.8M | −$40.8M | −$30.9M | −$17.2M | −$10.5M | −$266,370 | −$180,048 |
| Treasury stock | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Accumulated other comprehensive income | — | — | $0 | $0 | — | $0 | −$6,326 | $0 | $63,522 | $0 |
| Minority interest | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Total shareholders' equity | $7.1M | $822,013 | $6.2M | $9.6M | $6.6M | $2.1M | −$1.2M | −$4.4M | −$266,220 | −$81,492 |
| Key figures | ||||||||||
| Total debt | $266,806 | $260,160 | $184,400 | $202,895 | $315,673 | $1.3M | — | $1.7M | $275,197 | $13,619 |
| Net cash (debt) | $6.3M | $1.2M | $5.1M | $10.9M | $6.6M | $2.7M | — | −$1.7M | $247,020 | −$15,457 |
| Working capital | $7.9M | $2.4M | $5.5M | $9.1M | $6.1M | $1.8M | −$1.5M | −$3.8M | −$101,150 | −$81,492 |
| Tangible book value | $7.0M | $754,751 | $6.2M | $9.5M | $6.4M | $1.9M | −$1.4M | −$4.6M | −$447,110 | −$181,785 |
| Book value per share | $1.06 | $0.18 | $2.07 | $3.60 | — | — | — | — | — | — |
| Shares outstanding | 6.7M | 4.5M | 3.0M | 2.7M | — | — | — | — | — | — |
| Current ratio | 4.44 | 2.09 | 4.08 | 3.93 | 6.17 | 1.76 | 0.17 | 0.00 | 0.85 | 0.02 |
| Quick ratio | 3.40 | 0.74 | 2.97 | 3.61 | 5.88 | 1.71 | 0.15 | 0.00 | 0.77 | −0.02 |
| Debt / equity | 0.04 | 0.32 | 0.03 | 0.02 | 0.05 | 0.64 | — | — | — | — |
| Equity / assets | 65.6% | 15.3% | 77.2% | 74.9% | 82.6% | 43.4% | −232.4% | −2,009.8% | −35.2% | −4,433.7% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $2.0M | $2.8M | $3.6M | $6.6M | $8.0M | $1.3M | $1.1M | $1.5M | $1.6M | $2.4M | $2.7M | $5.3M |
| Cash & equivalents | $2.0M | $2.8M | $3.6M | $6.6M | $8.0M | $1.3M | $1.1M | $1.5M | $1.6M | $2.4M | $2.7M | $5.3M |
| Short-term investments | — | — | — | — | — | — | — | — | — | — | — | $0 |
| Receivables | $1.1M | $2.4M | $2.7M | $1.3M | $0 | $318,780 | $2.4M | $176,636 | $410,551 | $555,639 | $543,399 | $0 |
| Inventory | $2.3M | $1.9M | $1.7M | $2.2M | $1.9M | $1.8M | $1.9M | $2.6M | $1.8M | $1.3M | $1.6M | $1.7M |
| Other current assets | $351,986 | $283,716 | $177,447 | $164,292 | $233,363 | $280,444 | $277,661 | $359,094 | $261,477 | $407,777 | $259,966 | $263,746 |
| Total current assets | $5.8M | $7.4M | $8.1M | $10.2M | $10.2M | $3.8M | $5.7M | $4.6M | $4.1M | $4.7M | $5.1M | $7.3M |
| Property, plant & equipment (net) | $369,084 | $427,371 | $471,157 | $514,417 | $598,209 | $646,505 | $720,982 | $671,753 | $754,319 | $606,739 | $645,373 | $694,812 |
| Goodwill & intangible assets | $28,210 | $33,789 | $39,368 | $44,946 | $50,525 | $56,104 | $61,683 | $67,262 | $72,841 | $78,419 | $83,998 | $89,577 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $22,920 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total assets | $6.2M | $7.9M | $8.6M | $10.8M | $10.8M | $4.5M | $6.5M | $5.4M | $4.9M | $5.4M | $5.8M | $8.1M |
| Liabilities | ||||||||||||
| Accounts payable | $905,716 | $934,196 | $552,332 | $1.0M | $467,734 | $910,754 | $744,525 | $1.0M | $759,260 | $780,839 | $760,000 | $685,104 |
| Short-term debt | — | $114,612 | $127,003 | $123,658 | $120,373 | $104,440 | $104,137 | $65,768 | $80,180 | $121,896 | $132,739 | $129,116 |
| Deferred revenue | — | — | — | — | — | — | — | — | — | — | — | −$129,116 |
| Total current liabilities | $2.0M | $1.7M | $1.3M | $2.3M | $1.4M | $1.8M | $1.6M | $2.2M | $1.7M | $1.5M | $1.4M | $1.8M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $175,345 | $206,973 | $237,377 | $266,806 | $295,717 | $311,413 | $341,514 | $260,160 | $290,090 | $121,896 | $153,721 | $184,400 |
| Other long-term liabilities | $377,125 | $801,867 | $917,233 | $1.4M | $1.2M | $1.6M | $2.0M | $2.3M | $209,910 | $0 | $20,982 | $55,284 |
| Total liabilities | $2.4M | $2.5M | $2.2M | $3.7M | $2.6M | $3.3M | $3.6M | $4.5M | $1.9M | $1.5M | $1.4M | $1.8M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $8,703 | $8,616 | $50,413 | $50,006 | $49,825 | $31,385 | $30,841 | $30,816 | $27,847 | $26,322 | $24,831 | $23,929 |
| Retained earnings (deficit) | −$84.4M | −$82.1M | −$80.0M | −$78.6M | −$77.0M | −$75.5M | −$73.2M | −$75.0M | −$71.7M | −$68.9M | −$66.0M | −$62.7M |
| Accumulated other comprehensive income | — | — | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Total shareholders' equity | $3.8M | $5.4M | $6.4M | $7.1M | $8.2M | $1.1M | $2.9M | $822,013 | $3.0M | $3.9M | $4.4M | $6.2M |
| Key figures | ||||||||||||
| Total debt | $73,320 | $206,973 | $237,377 | $266,806 | $295,717 | $311,413 | $341,514 | $260,160 | $290,090 | $121,896 | $153,721 | $184,400 |
| Net cash (debt) | $2.0M | $2.6M | $3.3M | $6.3M | $7.7M | $1.0M | $792,836 | $1.2M | $1.3M | $2.3M | $2.5M | $5.1M |
| Working capital | $3.7M | $5.7M | $6.8M | $7.9M | $8.7M | $2.0M | $4.1M | $2.4M | $2.4M | $3.2M | $3.7M | $5.5M |
| Tangible book value | $3.7M | $5.3M | $6.4M | $7.0M | $8.1M | $1.1M | $2.9M | $754,751 | $2.9M | $3.8M | $4.3M | $6.2M |
| Book value per share | $0.43 | $0.63 | $0.76 | $1.06 | $1.01 | $0.22 | $0.57 | $0.18 | $0.66 | $0.89 | $1.10 | $1.59 |
| Shares outstanding | 8.7M | 8.6M | 8.4M | 6.7M | 8.1M | 5.2M | 5.1M | 4.5M | 4.6M | 4.3M | 4.0M | 3.9M |
| Current ratio | 2.84 | 4.37 | 6.41 | 4.44 | 7.13 | 2.13 | 3.64 | 2.09 | 2.42 | 3.06 | 3.68 | 4.08 |
| Quick ratio | 1.54 | 3.10 | 4.95 | 3.40 | 5.64 | 0.93 | 2.23 | 0.74 | 1.20 | 1.94 | 2.33 | 2.97 |
| Debt / equity | 0.02 | 0.04 | 0.04 | 0.04 | 0.04 | 0.28 | 0.12 | 0.32 | 0.10 | 0.03 | 0.03 | 0.03 |
| Equity / assets | 60.9% | 68.3% | 74.6% | 65.6% | 75.6% | 25.3% | 45.2% | 15.3% | 61.3% | 71.4% | 75.9% | 77.2% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed December 17, 2025); data from EODHD.
NMTC financial position
At the end of fiscal 2025 (September 30, 2025), NeuroOne Medical Technologies had total assets of $10.8 million (up 100.9% from a year earlier), total liabilities of $3.7 million and shareholders' equity of $7.1 million. It held $6.6 million in cash and short-term investments against $0.3 million of debt, a net cash position of $6.3 million. Its current ratio was 4.44. In the latest quarter (ended June 30, 2026) total assets were $6.2 million and equity $3.8 million.
Related: NMTC income statement, NMTC cash flow statement, NMTC key metrics. See the NMTC stock overview for the latest quote and news.
NMTC balance sheet FAQ
What are NeuroOne Medical Technologies's total assets?
NeuroOne Medical Technologies reported total assets of $10.8 million at the end of fiscal 2025 (September 30, 2025), compared with $5.4 million a year earlier.
How much debt does NeuroOne Medical Technologies have?
NeuroOne Medical Technologies had $0.3 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.04.
How much cash does NeuroOne Medical Technologies have?
NeuroOne Medical Technologies held $6.6 million in cash and short-term investments at the end of fiscal 2025; with $0.3 million of debt that is net cash of $6.3 million.
What is NeuroOne Medical Technologies's book value?
NeuroOne Medical Technologies's shareholders' equity (book value) was $7.1 million at the end of fiscal 2025, or $1.06 per share.
What is NeuroOne Medical Technologies's current ratio?
NeuroOne Medical Technologies had current assets of $10.2 million and current liabilities of $2.3 million, a current ratio of 4.44 (it can cover its short-term obligations).
How much goodwill does NeuroOne Medical Technologies have?
NeuroOne Medical Technologies carried $0.0 million of goodwill and intangible assets, 0.4% of total assets, at the end of fiscal 2025.